Pharmaron now offers a full array of services for biologics and cell and gene therapy (CGT). Learn more about Pharmaron’s expertise by registering for our monthly CGT webinar series, which is focused on identifying key cell and gene therapy questions that arise during drug discovery and development. Register here.


Pharmaron's team provides gene therapy development services from our state-of-the-art cGMP biomanufacturing facility in Liverpool, UK, which includes advanced analytical platforms, high-throughput process development equipment and purpose-designed viral and plasmid GMP manufacturing suites.

Download PDF: AAV Production: A Collaborative Approach to Accelerate Process Optimisation (Poster)

Article: Pharmaron - Taking Gene Therapy to the Next Level


Pharmaron aims to enable biologics innovators through extensive cell and gene therapy discovery and development capabilities. This is supported by a suite of analytical and functional assays and a full offering of in vitro/in vivo services highlighted by potency and safety to help identify the shortest pathway to approval.

Download PDF: IND and IMPD-Enabling Packages

Dowload PDF: CAR-T Therapy Services

Download PDF: CAR-T Potency Assays Services